Understanding Your Child's HSH Diagnosis
At a Glance
HSH is an inherited condition in which a gene change prevents a child from absorbing enough magnesium. The severe magnesium deficiency can lower calcium and cause infant seizures or spasms; blood tests and genetic testing confirm it, and magnesium treatment often restores calcium.
The journey to a diagnosis of Familial hypomagnesemia with secondary hypocalcemia (HSH, also known as HOMG1) is often one of the most stressful experiences a parent can face. It typically begins in the first weeks or months of life with terrifying symptoms like intractable seizures (seizures that do not respond to standard initial medications), muscle spasms, or extreme irritability [1][2]. Because these symptoms can mimic common infections or epilepsy, many families endure a “diagnostic odyssey,” moving from specialist to specialist before the root cause—a simple but critical mineral deficiency—is identified [3][4].
If you feel overwhelmed, it is important to know that your experience is a normal response to an extraordinary situation. You are now the parent of a child with an “ultra-rare” condition, and finding your way to this diagnosis required persistence and care.
Why This Diagnosis Was Hard to Find
HSH is exceptionally rare. A comprehensive 2022 review of medical literature found only 88 documented cases published worldwide over a 20-year period [2]. Other reports suggest the total number of known published cases globally is likely fewer than 100 [5][6]. (These case counts are not population prevalence estimates, but they reflect how rare it is).
Because of this rarity, most local pediatricians and even many specialists will never see a case of HSH in their entire careers. This often leads to a delay in diagnosis as doctors first rule out more common conditions. The breakthrough usually happens when a doctor checks serum magnesium levels—a test that is not always included in standard newborn blood work—and finds them to be profoundly low [1][5].
Understanding the “Gut-to-Blood” Connection
HSH is a genetic condition caused by mutations in the TRPM6 gene [7]. This gene is responsible for creating a specialized “gate” or channel in the lining of the intestines and the kidneys. Under normal circumstances, this channel allows magnesium from food and milk to actively pass into the bloodstream.
In a child with HSH, these channels do not work correctly:
- The Intestinal Barrier: Active magnesium absorption in the gut is severely impaired. The body struggles to absorb adequate magnesium from the diet, meaning much of it passes through the digestive system [8][1].
- The Kidney Response: In severe deficiency, healthy kidneys usually recognize the body is starving for magnesium and try to save every bit they can, resulting in a very low Fractional Excretion of Magnesium (FEMg)—often less than 2% [1][6]. While this low FEMg supports the idea of appropriate renal conservation, it requires careful clinical interpretation.
The Domino Effect: Magnesium and Calcium
A common source of confusion for parents is why their child also has low calcium levels (hypocalcemia). It helps to think of magnesium as the “key” that unlocks the body’s ability to manage calcium.
When magnesium levels drop to dangerous lows, the parathyroid glands (which control calcium) stop working properly [9]. They fail to release enough hormone, or the body becomes resistant to the hormone’s signals. This causes calcium levels to crash, which is what often triggers the muscle spasms and seizures that lead to the initial hospital visit [10][1]. Doctors call this secondary hypocalcemia because the calcium problem is a direct result of the magnesium problem. Once magnesium levels are restored through high-dose supplementation, calcium levels typically return to normal on their own [10][1].
Moving Forward with HSH
While an HSH diagnosis is life-changing, it is also a turning point. Identifying the TRPM6 mutation through genetic testing allows your care team to move from treating symptoms (like seizures) to treating the actual cause [2][11].
HSH is an autosomal recessive condition, meaning a child must inherit one copy of the mutated gene from each parent to be affected [2][12]. This knowledge can help you and your doctors understand the risks for future pregnancies and ensure siblings are screened immediately [3]. With consistent magnesium therapy, the long-term outlook for neurological development is encouraging, and many children achieve complete seizure control [13][14].
Common questions in this guide
What is HSH in children?
Why can HSH cause seizures and muscle spasms?
How is a child diagnosed with HSH?
What does a TRPM6 mutation mean for my child's care?
Will my child's low calcium improve after magnesium treatment?
Is HSH inherited, and could future children be affected?
What is the long-term outlook for children with HSH?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
About testing
Could a serum magnesium test help confirm this diagnosis?
Finding the cause
Would genetic testing of the TRPM6 gene help find the cause?
Family screening
Could other family members be screened for this condition?
Get notified when new evidence is published on Primary hypomagnesemia with secondary hypocalcemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Clinical Spectrum of Primary Hypomagnesemia with Secondary Hypocalcemia due to TRPM6 Mutation.
Aftab S, Anjum MN, Aslam N, et al.
Hormone research in paediatrics 2026; (99(7)):1045-1050 doi:10.1159/000547303.
PMID: 40853861 - 2
Case Report: Novel TRPM6 Mutations Cause Hereditary Hypomagnesemia With Secondary Hypocalcemia in a Chinese Family and a Literature Review.
Han Y, Zhao Y, Wang H, Huo L
Frontiers in pediatrics 2022; (10()):912524 doi:10.3389/fped.2022.912524.
PMID: 35903165 - 3
Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6.
Astor MC, Løvås K, Wolff AS, et al.
Endocrine connections 2015; (4(4)):215-22 doi:10.1530/EC-15-0066.
PMID: 26273099 - 4
A Rare Case of Neonatal Hypomagnesemia with Secondary Hypocalcemia Caused by a Novel Homozygous TRPM6 Gene Variant.
Uddin MS, Alradhi AY, Alqathani FMN, et al.
The American journal of case reports 2024; (25()):e942498 doi:10.12659/AJCR.942498.
PMID: 38528672 - 5
Familial hypomagnesemia with hypocalcemia: a rare cause of infantile seizures.
Srinivasan R, Ninama AC, Krishna S, Vasudevan A
CEN case reports 2023; (12(2)):139-145 doi:10.1007/s13730-022-00734-x.
PMID: 36131192 - 6
Three cases of hereditary hypomagnesemia with secondary hypocalcemia caused by novel TRPM6 gene mutations and a literature review.
Yang M, Zheng Z, Shan X, Luo Y
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(9)):917-925 doi:10.1515/jpem-2026-0185.
PMID: 42324811 - 7
Novel mutations in TRPM6 gene associated with primary hypomagnesemia with secondary hypocalcemia. Case report.
Papez J, Starha J, Slaba K, et al.
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2021; (165(4)):454-457 doi:10.5507/bp.2021.027.
PMID: 34012148 - 8
Intestinal hypomagnesemia in an Iranian patient with a novel TRPM6 variant: a case report and review of the literature.
Kamali F, Jamee M, Sayer JA, et al.
CEN case reports 2023; (12(4)):413-418 doi:10.1007/s13730-023-00785-8.
PMID: 36967423 - 9
Case Report: A Novel Non-Canonical Splice Site Variant (c.1638+7T>C) in TRPM6 Cause Primary Homagnesemia With Secondary Hocalcemia.
Song J, Lei J, Zhang J, et al.
Frontiers in pediatrics 2022; (10()):834241 doi:10.3389/fped.2022.834241.
PMID: 35692977 - 10
A novel TRPM6 variant (c.3179T>A) causing familial hypomagnesemia with secondary hypocalcemia.
Lomelino-Pinheiro S, Margarida B, Lages AS
Endocrinology, diabetes & metabolism case reports 2020; (2020()).
PMID: 32369769 - 11
Diagnostic strategy for inherited hypomagnesemia.
Horinouchi T, Nozu K, Kamiyoshi N, et al.
Clinical and experimental nephrology 2017; (21(6)):1003-1010 doi:10.1007/s10157-017-1396-7.
PMID: 28251383 - 12
A Novel Homozygous Mutation in the Transient Receptor Potential Melastatin 6 Gene: A Case Report.
Altıncık A, Schlingmann KP, Tosun MS
Journal of clinical research in pediatric endocrinology 2016; (8(1)):101-4 doi:10.4274/jcrpe.2254.
PMID: 26759217 - 13
Hereditary hypomagnesemia with secondary hypocalcemia caused by a novel mutation in TRPM6 gene.
Dokurel Çetin İ, Betül Gerik-Çelebi H, Demiral M, Çetin O
Journal of pediatric endocrinology & metabolism : JPEM 2024; (37(2)):184-188 doi:10.1515/jpem-2023-0378.
PMID: 38084506 - 14
A pediatric case of hypomagnesemia 1 (HOMG1) caused by novel compound heterozygous mutations in TRPM6.
Goda T, Komatsu H, Nozu K, Nakajima H
Human genome variation 2019; (6()):13 doi:10.1038/s41439-019-0043-0.
PMID: 30911400
This page explains familial hypomagnesemia with secondary hypocalcemia in children for informational purposes only and does not constitute medical advice. Your child's pediatrician, pediatric nephrologist, and geneticist should interpret laboratory and genetic results and guide treatment.